Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Related Citations for PubMed (Select 11782357)


Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity.

Filippova GN, Qi CF, Ulmer JE, Moore JM, Ward MD, Hu YJ, Loukinov DI, Pugacheva EM, Klenova EM, Grundy PE, Feinberg AP, Cleton-Jansen AM, Moerland EW, Cornelisse CJ, Suzuki H, Komiya A, Lindblom A, Dorion-Bonnet F, Neiman PE, Morse HC 3rd, Collins SJ, Lobanenkov VV.

Cancer Res. 2002 Jan 1;62(1):48-52.


Regulatory factor interactions and somatic silencing of the germ cell-specific ALF gene.

Kim M, Li D, Cui Y, Mueller K, Chears WC, DeJong J.

J Biol Chem. 2006 Nov 10;281(45):34288-98. Epub 2006 Sep 11.


The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells.

Tiffen JC, Bailey CG, Marshall AD, Metierre C, Feng Y, Wang Q, Watson SL, Holst J, Rasko JE.

Int J Cancer. 2013 Oct 1;133(7):1603-13. doi: 10.1002/ijc.28184. Epub 2013 May 2.


Familial cases of point mutations in the XIST promoter reveal a correlation between CTCF binding and pre-emptive choices of X chromosome inactivation.

Pugacheva EM, Tiwari VK, Abdullaev Z, Vostrov AA, Flanagan PT, Quitschke WW, Loukinov DI, Ohlsson R, Lobanenkov VV.

Hum Mol Genet. 2005 Apr 1;14(7):953-65. Epub 2005 Feb 24.


CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease.

Ohlsson R, Renkawitz R, Lobanenkov V.

Trends Genet. 2001 Sep;17(9):520-7. Review.


Physical and functional interaction between two pluripotent proteins, the Y-box DNA/RNA-binding factor, YB-1, and the multivalent zinc finger factor, CTCF.

Chernukhin IV, Shamsuddin S, Robinson AF, Carne AF, Paul A, El-Kady AI, Lobanenkov VV, Klenova EM.

J Biol Chem. 2000 Sep 22;275(38):29915-21.


Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.

Borel F, Barilla KC, Hamilton TB, Iskandar M, Romaniuk PJ.

Biochemistry. 1996 Sep 17;35(37):12070-6.


An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes.

Filippova GN, Fagerlie S, Klenova EM, Myers C, Dehner Y, Goodwin G, Neiman PE, Collins SJ, Lobanenkov VV.

Mol Cell Biol. 1996 Jun;16(6):2802-13.


Functional phosphorylation sites in the C-terminal region of the multivalent multifunctional transcriptional factor CTCF.

Klenova EM, Chernukhin IV, El-Kady A, Lee RE, Pugacheva EM, Loukinov DI, Goodwin GH, Delgado D, Filippova GN, León J, Morse HC 3rd, Neiman PE, Lobanenkov VV.

Mol Cell Biol. 2001 Mar;21(6):2221-34.


Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.

Cui H, Niemitz EL, Ravenel JD, Onyango P, Brandenburg SA, Lobanenkov VV, Feinberg AP.

Cancer Res. 2001 Jul 1;61(13):4947-50.


Differential effect of zinc finger deletions on the binding of CTCF to the promoter of the amyloid precursor protein gene.

Quitschke WW, Taheny MJ, Fochtmann LJ, Vostrov AA.

Nucleic Acids Res. 2000 Sep 1;28(17):3370-8.


CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms.

Klenova EM, Nicolas RH, Paterson HF, Carne AF, Heath CM, Goodwin GH, Neiman PE, Lobanenkov VV.

Mol Cell Biol. 1993 Dec;13(12):7612-24.


The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer.

Klenova EM, Morse HC 3rd, Ohlsson R, Lobanenkov VV.

Semin Cancer Biol. 2002 Oct;12(5):399-414. Review.


BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma.

Loukinov DI, Pugacheva E, Vatolin S, Pack SD, Moon H, Chernukhin I, Mannan P, Larsson E, Kanduri C, Vostrov AA, Cui H, Niemitz EL, Rasko JE, Docquier FM, Kistler M, Breen JJ, Zhuang Z, Quitschke WW, Renkawitz R, Klenova EM, Feinberg AP, Ohlsson R, Morse HC 3rd, Lobanenkov VV.

Proc Natl Acad Sci U S A. 2002 May 14;99(10):6806-11.


Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1.

Rakha EA, Pinder SE, Paish CE, Ellis IO.

Br J Cancer. 2004 Oct 18;91(8):1591-6.


Inhibition of Wilms tumor 1 transactivation by bone marrow zinc finger 2, a novel transcriptional repressor.

Lee TH, Lwu S, Kim J, Pelletier J.

J Biol Chem. 2002 Nov 22;277(47):44826-37. Epub 2002 Sep 17.


CTCF gene mutations in invasive ductal breast cancer.

Aulmann S, Bläker H, Penzel R, Rieker RJ, Otto HF, Sinn HP.

Breast Cancer Res Treat. 2003 Aug;80(3):347-52.


KRAB-independent suppression of neoplastic cell growth by the novel zinc finger transcription factor KS1.

Gebelein B, Fernandez-Zapico M, Imoto M, Urrutia R.

J Clin Invest. 1998 Dec 1;102(11):1911-9.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk